Prospera Financial Services’s BioMarin Pharmaceuticals BMRN Stock Holding History

Prospera Financial Services’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$247K	Buy	4,228 +462	+12%	+$29.1K	﹤0.01%	1349
2026 Q2	$215K	Buy	+3,766	New	+$206K	﹤0.01%	1370
2026 Q1	–	Sell	-3,395	Closed	-$202K	–	1427
2025 Q4	$202K	Buy	+3,395	New	+$185K	﹤0.01%	1300
2024 Q1	–	Sell	-2,398	Closed	-$231K	–	1098
2023 Q4	$231K	Buy	+2,398	New	+$212K	0.01%	953
2022 Q3	–	Sell	-1,466	Closed	-$121K	–	921
2022 Q2	$121K	Sell	1,466 -218	-13%	-$17.4K	0.01%	852
2022 Q1	$130K	Buy	+1,684	New	+$141K	0.01%	1027
2020 Q4	–	Sell	-375	Closed	-$29K	–	782
2020 Q3	$29K	Buy	+375	New	+$37.9K	0.01%	782

Other funds holding BMRN

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

ARGA Investment Management Stamford, Connecticut $3.94B AUM 28.9% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Prospera Financial Services's BMRN Position: Q3 2026 in Review

Prospera Financial Services increased its BioMarin Pharmaceuticals (BMRN) stake by 12% in Q3 2026, buying an estimated $29.1K and bringing the position to 4,228 shares worth $247K. The position accounts for ﹤0.01% of the portfolio, ranked #1349.

Prospera Financial Services first reported a position in BMRN in Q3 2020 and has held it in 7 quarters since. 271 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.

Prospera Financial Services held 4,228 shares of BioMarin Pharmaceuticals worth $247K as of Q3 2026.
Prospera Financial Services bought 462 BioMarin Pharmaceuticals shares in Q3 2026, an estimated $29.1K.
BioMarin Pharmaceuticals made up ﹤0.01% of Prospera Financial Services's portfolio in Q3 2026, its #1349 holding.
Prospera Financial Services first reported a position in BioMarin Pharmaceuticals in Q3 2020 and has held it in 7 quarters since.
271 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.

Based on Prospera Financial Services's 13F filing for Q3 2026, filed 4 Nov 2026.